-PTI MUMBAI: The cost of production of paddy in Andhra Pradesh was higher than the minimum support price (MSP) of Rs 1,080 per quintal in the last year mainly because of higher expenditure on wages, says the latest study undertaken by the RBI's Research wing. Andhra Pradesh is one of the leading producing states in the country. The study, conducted by the Development Research Group (DRG) of RBI, also said the Commission for...

-Deccan Herald A study has found India to be the lowest on nutrition parameters, sharing the last rank with Democratic Republic of Congo and Yemen. India performed lowest at the level of policy as well as implementation. Nutrition barometer, the study carried out by Save the Children, compared commitments and outcomes of 36 countries which together account for 90 per cent of the world’s stunted children. Components for the commitment included a snapshot...

-The Telegraph The Planning Commission has accepted a proposal by scientists to create new academic centres for cognitive science, cyber security and other fields to be shared by scholars and faculty from universities across India. The proposal for inter- university centres (IUCs) is among key initiatives in science and technology planned during the 12th Five-Year Plan that covers the period up to 2017, K. Kasturirangan, a member of the Planning Commission, told...

-PTI The Punjab government today inked a Memorandum of Understanding with The Energy and Resources Institute (TERI) to address issues pertaining to climate change, sustainable development, conservation and optimal use of water. The MoU was signed by Principal Secretary of science, technology, environment and non-conventional energy department, Karan Avtar Singh and Director General of TERI, Dr Rajendra K Pachauri, in the presence of Chief Minister Parkash Singh Badal. Appreciating the joint efforts taken...

-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...